Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
2010
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Antibiotic resistance andcagAgene correlation: A looming crisis ofHelicobacter pylori
2012
Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
2009
Importance of antimicrobial susceptibility testing for the management of eradication inHelicobacter pyloriinfection
2017
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
2015
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
2007 Guideline for the Management of Ureteral Calculi
2007 Standout
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
2011
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
2010
Risk factors for neuropathic pain in diabetes mellitus
2016
Helicobacter pylori treatment in the era of increasing antibiotic resistance
2010
Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?
2005
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Accuracy of Monoclonal Stool Tests for Determining Cure of Helicobacter pylori Infection After Treatment
2010
Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
2011
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
2011
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2017
Levofloxacin/amoxicillin-based schemesvsquadruple therapy forHelicobacter pylorieradication in second-line
2012
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
2014
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Prevalence of Primary and Secondary Antimicrobial Resistance of H elicobacter pylori in K orea from 2003 through 2012
2012
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A Streptococcus
2016 StandoutNobel
Indwelling Ureteral Stents: Evaluation of Symptoms, Quality of Life and Utility
2003 Standout
Cytokines in Inflammatory Disease
2019
Tetrodotoxin (TTX) as a Therapeutic Agent for Pain
2012
Natural product and natural product derived drugs in clinical trials
2014 Standout
OPTIMAL METHOD OF URGENT DECOMPRESSION OF THE COLLECTING SYSTEM FOR OBSTRUCTION AND INFECTION DUE TO URETERAL CALCULI
1998
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection
2008
Systematic review and meta-analysis of genetic risk factors for neuropathic pain
2018
Works of Lin‐Li Chang being referenced
Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain
2009
TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation
2018
Group A Streptococcal Necrotizing Fasciitis in the Emergency Department
2013
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
2009
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice
2016
Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3expression and decreasing spinal microglial activation
2011
Comparison of a new office-based stool immunoassay and 13C-UBT in the diagnosis of current Helicobacter pylori infection
2006
Experience in the morbidity associated with double-J catheter indwelling and its management.
1993
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan
2003